Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-07-22
2008-07-22
Stockton, Laura L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S343500
Reexamination Certificate
active
07402602
ABSTRACT:
A method of treating cardiac rhythm disorders linked with neurodegenerating depression, bipolar disorders and irritable bowel disorders in warm-blooded animals in need thereof by administering a compound of the formulawherein the substituents are defined as in the specification.
REFERENCES:
patent: 1046248 (1966-10-01), None
patent: WO-0071120 (2000-11-01), None
Gregory Y. H. Lip et al., The Pharmaceutical Journal, vol. 264, No. 7093, pp. 622-626, Apr. 22, 2000.
Bigg Dennis
Liberatore Anne-Marie
Pommier Jacques
Muserlian Charles A.
Societe de Conseils de Recherches Et d'Applications Scientifique
Stockton Laura L
LandOfFree
Imidazole derivatives modulating the sodium channels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole derivatives modulating the sodium channels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives modulating the sodium channels will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2773229